Biolase Stock Story

BIOL Stock  USD 0.14  0.01  6.67%   
About 56% of BIOLASE's investor base is looking to short. The analysis of overall sentiment of trading BIOLASE stock suggests that many investors are alarmed at this time. BIOLASE's investor sentiment overview provides quick insight into current market opportunities from investing in BIOLASE. The current market sentiment, together with BIOLASE's historical and current headlines, can help investors time the market. In addition, many technical investors use BIOLASE stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
BIOLASE stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of BIOLASE daily returns and investor perception about the current price of BIOLASE as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for BIOLASE.

BIOLASE Latest Timeline

BIOLASE is listed for 0.14. The company has price-to-book (P/B) ratio of 0.77. Some equities with similar Price to Book (P/B) outperform the market in the long run. BIOLASE recorded a loss per share of 29.44. The entity last dividend was issued on the 24th of June 2005. The firm had 1:100 split on the 28th of July 2023.
When determining whether BIOLASE is a strong investment it is important to analyze BIOLASE's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BIOLASE's future performance. For an informed investment choice regarding BIOLASE Stock, refer to the following important reports:
Check out BIOLASE Hype Analysis, BIOLASE Correlation and BIOLASE Performance.
For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for BIOLASE Stock analysis

When running BIOLASE's price analysis, check to measure BIOLASE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIOLASE is operating at the current time. Most of BIOLASE's value examination focuses on studying past and present price action to predict the probability of BIOLASE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIOLASE's price. Additionally, you may evaluate how the addition of BIOLASE to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is BIOLASE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIOLASE. If investors know BIOLASE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIOLASE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(29.44)
Revenue Per Share
38.469
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.29)
Return On Equity
(6.03)
The market value of BIOLASE is measured differently than its book value, which is the value of BIOLASE that is recorded on the company's balance sheet. Investors also form their own opinion of BIOLASE's value that differs from its market value or its book value, called intrinsic value, which is BIOLASE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIOLASE's market value can be influenced by many factors that don't directly affect BIOLASE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIOLASE's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIOLASE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIOLASE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.